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GENETIC DISORDERS – DEVELOPMENT
Laminin-1 reexpression in Alport mouse glomerular
basement membranes1
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Laminin-1 reexpression in Alport mouse glomerular basement basement membrane (GBM) (reviewed in [1]). Specifi-
membranes. cally, vascular cleft basement membranes of the earliest,
Background. Alport disease is a heritable basement mem- comma- and S-shaped nephric figures contain1(IV) and
brane disorder caused by mutations in genes encoding the 3,
2(IV) collagen and laminin-1 (111 heterotrimers).4, or 5 chains of type IV collagen, which normally comprise
In intermediate, capillary loop stage glomeruli, GBMsthe collagenous network of mature glomerular basement mem-
contain 1(IV), 2(IV), 3(IV), 4(IV), and 5(IV) col-branes (GBMs). In Alport disease, the 3(IV), 4(IV), 5(IV)
collagen network is absent and substituted for by 1(IV), and lagen chains, and laminin-11 (521) makes its appear-
2(IV) collagen, which normally is present only in developing, ance. Maturing-stage glomeruli GBMs contain predomi-
immature GBMs. The disease is marked by progressive GBM nantly 3(IV), 4(IV), 5(IV) collagen and laminin-11.thickening and delamination, proteinuria, and renal failure. In
Laminin-1 is apparently completely absent from matureaddition to collagen IV dysregulation, abnormal GBM laminins
glomeruli in humans, and in mice this isotype, along withalso occur and may contribute to the pathogenesis of Alport
glomerulopathy. laminin-2 (211), is confined to mesangial matrices [1].
Methods. To investigate laminin dysregulation in a mouse Although the reasons for these temporally controlled
model of Alport disease, we used antibodies specific for isoform substitutions in the GBM are not known, striking
laminin-1 and -1 chains (to recognize laminin-1), and -5
glomerular phenotypes are observed when collagen typechain (to recognize laminin-11), and evaluated their distribu-
IV or laminin isoforms are mutated. Humans with muta-tion during glomerular development in 3(IV) collagen-defi-
tions in the 3, 4, or 5(IV) chains suffer from Alportcient mice.
Results. Developing glomeruli of infant 3(IV) collagen syndrome, which in kidney is characterized by an absence
knockout mice underwent normal down-regulation of laminin-1, of the 3(IV), 4(IV), 5(IV) collagen network, the
but laminin-1 chains were then reexpressed in maturing glo- protracted presence of 1(IV) and 2(IV) collagenmeruli, becoming concentrated in the subepithelial GBM pro-
chains in the GBM, a progressive delamination andjections typical of Alport disease. Immunoelectron microscopy
thickening of the GBM, proteinuria, and renal insuffi-showed that laminin-1 reexpression took place in both glomer-
ular endothelial cells and podocytes. ciency (reviewed in [2]). At least some of these changes
Conclusions. The absence of a 3(IV), 4(IV), 5(IV) net- are believed to be due to the susceptibility of 1(IV)
work may stimulate reexpression of laminin-1 by Alport mouse and 2(IV) collagen chains to proteolytic degradation,
endothelial cells and podocytes. This abnormal GBM, which a process that occurs much less readily in the cysteine-is more characteristic of immature glomeruli, may promote
enriched 3(IV), 4(IV), and 5(IV) collagen networkpodocyte foot process effacement and reversion to a less differ-
normally found in mature glomeruli [3]. Autosomal-entiated state.
recessive and X-linked models in dogs display very simi-
lar histopathologic features to human Alport syndrome
[4–6]. Three different mouse models of Alport diseaseGlomerular morphogenesis is marked by the progres-
have been created through the deletion of the noncollag-sive appearance and disappearance of different type IV
enous 1 (NC1) domain of 3(IV) collagen [7, 8] or ancollagen and laminin isotypes from developing glomerular
insertional mutation knocking out both the 3(IV) and
4(IV) collagen genes [9]. In all three cases, mice de-
1See Editorial by Miner, p. 1158. velop renal phenotypes that closely parallel those seen
in humans, indicating that the formation and mainte-Key words: collagen IV, endothelium, podocytes, glomerular develop-
ment. nance of an 3(IV), 4(IV), 5(IV) collagen network is
crucial for normal GBM structure and function. Dele-Received for publication July 5, 2002
tions of the laminin 5 or 2 chains (both found inand in revised form September 4, 2002
Accepted for publication October 10, 2002 laminin-11) in mice also result in prominent glomerular
defects, including nonvascular glomeruli (5) [10], and 2003 by the International Society of Nephrology
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massive proteinuria accompanied by podocyte foot pro- mine-conjugated secondary antibodies came from ICN
Biomedicals (Costa Mesa, CA, USA).cess effacement (2) [11].
A number of studies have examined GBM structure
Immunolocalizationand composition in human Alport patients and in canine
Deeply anesthetized mice underwent nephrectomy.and mouse models (reviewed in [12]). Although early
For immunofluorescence microscopy, kidneys were fro-reports did not detect major errors in glomerular laminin
zen in isopentane chilled in a dry ice–acetone bath. Forisoform distribution, a comprehensive immunofluores-
immunofluorescence labeling with chain-specific anti-cence study using well-characterized, chain-specific anti-
bodies against laminin 1, 5, and 1 chains, as well asbodies was published recently showing potentially im-
the 3 chain of collagen type IV, cryostat sections wereportant changes in GBM laminin composition [12]. This
fixed for 10 minutes in 100% methanol at 20C. Afteranalysis revealed that Alport GBMs abnormally contain
labeling with primary antibodies, sections were washedlaminin 2 chain [probably as part of the laminin-2 and/or
with phosphate-buffered saline (PBS), incubated with ap--4 isotype (211 and 221, respectively)] and, in
propriate fluorochrome-conjugated secondary antibod-both mice and dogs, laminin 1 and 1 chains, probably
ies, and permanently coverslipped with Prolong mount-representing laminin-1 [12]. In the study presented here,
ing media (Molecular Probes, Inc., Eugene, OR, USA).we concentrated on the temporal expression pattern and
For immunoelectron microscopy, anesthetized micedistribution of laminin 1 and 1 in the immature Alport
received intravenous injections of 0.1 mL 1.0 mg/mLmouse. We were interested in whether the laminin iso-
antilaminin 1 chain monoclonal antibody (mAb) 8B3-form switching process was operative in developing Al-
HRP or antilaminin 1 chain mAb 5A2-HRP and al-port kidney and specifically if laminin-1 was expressed
lowed to recover. The next day, mice were reanesthe-continuously from the vascular cleft stages of early glo-
tized, and kidneys were fixed in situ by the subcapsu-meruli or reexpressed at a later stage during the disease
lar injection of Karnovsky’s fixative. Vibratome sections,process. We also used immunoelectron microscopy to
50 m thick, were then processed for peroxidase histo-identify the ultrastructural distribution and cellular ori-
chemistry as before [16], and postfixed with 2% osmiumgins of these aberrant laminin chains in the GBM. Our
tetroxide. In other cases, postfixation immunolabelingfindings show that laminin-1 down-regulation occurred
of kidney tissue from uninjected animals was processednormally in the Alport mouse but that derepression oc-
exactly as described earlier to identify cells engaged incurred shortly thereafter. Further, we show that lami-
laminin biosynthesis [17]. Tissues were embedded innin-1 originated in the diseased glomerulus from both
Polybed 812 (Polysciences, Warrington, PA, USA) andendothelial cells and podocytes.




Mice containing a targeted deletion of the NC1 do- Dysregulation of the laminin isoform switch in
main of the 3(IV) collagen chain [8] were obtained Alport kidneys
from Jackson Laboratory (Jax mice strain 129-Col4a3tm1Dec, As indicated earlier, abnormal laminin isoforms have
Bar Harbor, ME, USA). Our colony was maintained by been documented in human Alport disease, as well as
heterozygote interbreeding, and progeny were genotyped in dog and mouse models [12]. Specifically, laminin-1
by polymerase chain reaction (PCR). Heterozygous and (111), which normally occurs within nascent GBM
wild-type littermates served as controls for observations found in vascular clefts of early nephric figures, is ordi-
made in 3(IV) collagen null mice. narily replaced by laminin-11 (5 21) in mature GBM.
However, in mouse and dog Alport models, laminin-1
Antibodies and -11 chains are both observed in diseased GBMs [12].
Monoclonal rat antimouse laminin 1 and 1 chain To evaluate whether the abnormal presence of lami-
IgGs (designated 8B3 and 5A2, respectively) were pre- nin-1 in mouse Alport GBM reflects its persistent expres-
pared and characterized as previously described [13, 14]. sion throughout glomerular development, we examined
For some experiments, these immunoglogulins (IgGs) kidneys from infant 3(IV) collagen knockouts and com-
were directly conjugated to activated horseradish peroxi- pared them with wild-type and heterozygous littermates.
dase (HRP) [13]. Polyclonal antibody against laminin 5 In wild type and heterozygous mice, laminin 1 chain
[15] chain was kindly provided by Dr. Jeffrey Miner was observed in vascular cleft basement membranes of
(Washington University, St. Louis, MO, USA). Anticol- the earliest nephric figures, and almost entirely disap-
lagen 3(IV) antibody (MAB3) was purchased from peared from GBMs of capillary loop stage glomeruli
(Fig. 1a). In maturing stage glomeruli from the sameWieslab, AB (Lund, Sweden). Fluorescein and rhoda-
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Fig. 1. Immunofluorescence micrographs show-
ing the distribution of laminin 1 chain in 3-day-
old wild-type (WT) mice and 3(IV) collagen
knockout (KO) littermates. (a) In WT mice,
laminin 1 chain is observed in vascular cleft
basement membrane (arrow) but has disap-
peared from capillary loop stage glomerular
basement membrane (GBM) (*). (b) In matur-
ing stage glomeruli, laminin 1 chain is re-
stricted to mesangial matrices; peripheral loop
GBMs are negative. (c) Similar to WT mice,
laminin 1 chain is present in vascular clefts
of KO mice (arrows), but quickly disappears
in capillary loop stage glomeruli (*). (d and e)
Maturing stage GBMs of KOs contain laminin
1 chain in peripheral loop GBMs (arrows)
as well as mesangial matrices.
kidney section, laminin 1 chain was seen in mesangial
matrices but was absent from peripheral loop GBMs
(Fig. 1b). Similar to wild-type and heterozygous mice,
laminin 1 was expressed in vascular cleft basement mem-
branes of 3(IV) collagen knockout mice and quickly
disappeared in capillary loop stage GBMs (Fig. 1c). In
maturing stage GBMs of knockouts, however, laminin 1
chain reappeared and was clearly observed within GBMs
of several peripheral capillary loops (Fig. 1 d and e).
This evidence indicates, therefore, that laminin 1 down-
regulation proceeded normally in early capillary loop
stage glomeruli in the knockouts, but that synthesis of
this laminin chain then abnormally resumed in maturing-
stage glomeruli.
Immunolocalization of laminin 1 and 1 chains
within Alport mouse GBMs
Glomerular morphogenesis concludes by 2 weeks of
age in the mouse. Figure 2 shows the glomerular distribu-
tion of collagen 3(IV), and laminin 1 and 1 chains
of laminin-1 in 2-week-old wild-type (Fig. 2 a, c, and e)
and 3(IV) collagen knockouts (Fig. 2 b, d, and f). At
this age, laminin-1 is normally confined in glomeruli to
the mesangial matrices, whereas laminin-11 is found in
GBMs. As shown here, laminin 1 and 1 chains were
confined to mesangial areas in wild type glomeruli (Fig.
2 c and e), but these chains were also present in GBMs
as well as mesangia of Alport mice at this age (Figs. 2
d and f). To determine the ultrastructural location of
laminin 1 and 1 chains, we carried out immunoelec-
tron microscopy on 4-week-old Alport mice and hetereo- Fig. 2. Distribution of3(IV) collagen, and laminin1 and1 chains in
glomeruli of 2-week-old wild-type (WT) and 3(IV) collagen knockoutzygous and wild type littermates as controls. Consistent
(KO) littermates. Collagen 3(IV) is strongly positive in glomerularwith the immunofluorescence findings shown in Figures
basement membranes (GBMs) of WT (a), but absent in KOs (b). Lami-
2c and 2e, laminin 1 and 1 chains were found exclu- nin 1 and 1 chains are prominent in mesangial matrices of WT mice
(c) and (e ) but also seen in GBMs of KOs [arrows in (d) and (f )].sively in mesangial matrices of mature glomeruli at this
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Fig. 3. Electron micrograph from a 4-week-old heterozygous (Het)
mouse showing normal distribution of laminin 1 chain [using mono-
clonal antibody (mAb) 5A2-horseradish peroxide (HRP) histochemis-
try as described in the Methods section]. Peroxidase reaction product
is found exclusively in mesangial matrix (MM); glomerular basement
membranes (GBMs) are negative for laminin 1 chain at this age.
Abbreviations are: CL, capillary lumen; En, endothelium; M, mesangial
cell; Po, podocyte; US, urinary space.
Fig. 4. Electron micrographs of glomerular capillaries from 4-week-
age and were absent from GBMs in heterozygous and old3(IV) collagen knockout (KO) (A) mouse labeled with antilaminin
1 chain [monoclonal antibody (mAb 8B3)-horseradish peroxide (HRP)wild-type mice. Figure 3 shows localization for laminin
(B)] conjugate. Several subepithelial GBM projections contain laminin1 chain; an identical localization pattern was seen for
1 chain (arrows), but some do not (arrowheads).
laminin 1 chain in wild-type and heterozygous mice
(not shown). In 3(IV) collagen knockout mouse GBMs,
by contrast, antilaminin 1 chain antibody bound abun-
dantly to many of the irregular, supepithelial GBM out Origin of laminin-1 in Alport GBMs
pockets commonly seen (Fig. 4). Not all of these GBM To examine the cellular sources for these abnormally
projections contained the laminin 1 chain, however expressed laminin chains, we carried out postfixation im-
(Fig. 4). On the other hand, laminin 1 chain was de- munocytochemistry. When sections of lightly fixed 4-week-
tected in essentially all of the GBM irregularities of Al- old 3(IV) collagen knockout mice were incubated with
port mice (Fig. 5), although there were variations in
antilaminin 1- or antilaminin 1-HRP conjugates, per-
peroxidase reaction product intensity between separate
oxidase reaction product was identified within biosyn-out pockets. We suspect that labeled lengths of GBM
thetic pathways of both endothelial cells and podocytesthat were negative for laminin 1 chain but positive for
(Fig. 6). Intracellular labeling in these cells for laminin-11 chain probably contained laminin 2 chain [constitut-
chains was never observed in kidneys of wild-type or het-ing laminin-2 (1, 12)], but we did not pursue this possibil-
erozygous littermates processed at this age.ity further. Remarkably, despite the complete absence of
3(IV) collagen, areas within many glomerular capillary Colocalization of laminin 1, 1, and 5 chains
loops appeared to be ultrastructurally normal (Fig. 5).
To compare the distribution of laminin 1 and 1Importantly, however, regions of the glomerular capil-
(laminin-1) with laminin 5 (presumably laminin-11), welary containing lengths of GBM with normal ultrastruc-
carried out double-label immunofluorescence in 4-week-ture covered by typical, regularly interdigitating foot pro-
old Alport mice and normal littermates. As shown incesses were not labeled with either antilaminin 1 or
the top panel of Figure 7, which illustrates distributions1 antibodies. In other words, laminin-1 chains were
in heterozygous mice, laminin 1 was found in mesangialobserved only in those areas of peripheral capillary loops
areas whereas laminin 5 was contained within its usual,containing GBM irregularities and podocyte foot process
effacement. GBM, location. In knockouts, by contrast, laminin 1
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Fig. 6. Lightly fixed sections of 4-week-old 3(IV) collagen knockout
mouse kidney incubated with antilaminin1- and1-chain [monoclonal
antibody (mAbs)-horseradish peroxide (HRP), as indicated. Intracellu-
lar labeling (arrows) for both chains is observed within glomerular
endothelial cells (En) and podocytes (Po).
gen (as well as absence of 4 and 5(IV) chains), theFig. 5. Glomerular capillary loops from 4-week-old 3(IV) collagen
knockout (KO) (A) mouse labeled with antilaminin 1 chain [mono- synthesis of laminin-1 abruptly resumed. Second, abnor-
clonal antibody (mAb 5A2)-horseradish peroxide (HRP) (B )] conju- mal laminin-1 deposition was sustained in Alport GBMs
gate. Most of the abnormal glomerular basement membrane (GBM)
of mature mice and this isoform was derived, at least insegments contain laminin 1 chain (arrows). Note that capillary loops
with normal morphology (*) do not contain aberrant laminin 1 chain part, from both glomerular endothelial cells and podo-
expression. cytes. Finally, many of the GBM irregularities typical
of Alport glomeruli contained both laminin-1 and -11
chains, whereas laminin-1 was generally absent from
lengths of morphologically normal GBM. These findingsand 1 chains were commonly found together with lami-
suggest that the GBM and podocyte structural irregulari-nin5 chain in GBM out pockets, indicating the presence
ties seen in Alport mice may result from the focal pres-of both laminin-1 and -11 isoforms in the same GBM
ence of both laminin-1 and -11 isoforms, together withsegments (Fig. 7).
the absence of the 3, 4, 5(IV) collagen network.
We previously carried out an immunoelectron micro-
DISCUSSION scopic examination of the temporal expression patterns
for laminin-1 and -11 chains in wild-type mice [17]. Nor-Earlier studies have provided evidence showing ab-
mally, laminin 1 chain is abruptly down-regulated afternormal laminin deposition in GBMs in humans with Al-
vascular cleft stages (comma- and S-shaped nephric fig-port syndrome, as well as in mouse and dog models of
ures) and is undetectable in GBMs of capillary loop stagethe disease [8, 12]. In an effort to understand better
and maturing glomeruli [17]. Normal down-regulationthe progression of this disorder, we examined immature
was also observed in the 3-day-old Alport kidneys exam-Alport mice to explore the ultrastructural distribution
ined here, but laminin 1 chain was then found abun-and cellular sources for some of these abnormally ex-
dantly in GBMs of late capillary loop and maturing stagepressed laminin chains. Our results show that laminin-1
glomeruli in the same samples.down-regulation occurred normally and on schedule in
What might stimulate the renewed synthesis of lami-early glomerular development of Alport mice. However,
and presumably because of the absence of 3(IV) colla- nin-1 in Alport mice? We propose that developing glo-
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Fig. 7. Double-label immunofluorescence of 4-week-old heterozygous (Het) and 3(IV) collagen knockout (KO) kidney sections labeled with
anti-laminin 1, 5, or 1 antibodies, as indicated. As shown in the heterozygous (Het) panel, laminin 1 is found in mesangial matrices, whereas
laminin 5 is contained within GBMs. In KOs, by contrast, laminin 1 and 1 chains are often found together with laminin 5 chain in peripheral
capillary loop glomerular basement membranes (GBMs) (arrows in merged fields).
merular endothelial cells and podocytes continually mon- and located specifically at the foot process-GBM inter-
face, result in failure of foot process development anditor their evolving GBM substrates and this surveillance
may, in part, dictate cell differentiation programs. If the perinatal death [18]. Importantly, the GBM is also disor-
ganized in these integrin mutants, and probably reflectsGBM is assembled incorrectly, perhaps the adherent cells
attempt to compensate for such defects by reversing/alter- reciprocal interactions occurring dynamically between
adherent cells and the GBM [18]. Similar conclusionsing their normal isoform substitution patterns. In turn,
these temporally abnormal GBMs may thwart normal were reached on analysis of laminin 5 and 2 mutant
mice. When laminin 5 chain is deleted, an intact GBMendothelial and podocyte differentiation and matura-
tion. In Alport mice, the failure of appearance of a colla- is not assembled (or cannot be maintained) and avascular
glomeruli develop, apparently because of an inability ofgen 3, 4, 5(IV) network in capillary loop stage glo-
meruli may have been sensed by endothelial cells and endothelial cells to bind to the disrupted/absent GBM
[10]. On the other hand, when laminin 2 chain is de-podocytes, which then responded by resuming synthesis
of laminin-1. Support for such an outside-in signaling role leted, a recognizable GBM is assembled but podocyte
foot processes are abnormally broadened, suggestingby developing GBM comes from studies on 3 integrin
knockout mice. Mutations affecting 31 integrin, which that laminin-11 is important for normal foot process regis-
tration and/or maintenance [11].is the principal integrin in the peripheral glomerular wall
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Fig. 8. Diagram summarizing temporal changes in laminin and collagen IV chain expression during glomerular capillary wall development as
shown in this and previous studies, using chain specific antibodies [1, 7, 15, 17]. (A) Vascular cleft basement membranes of early nephric figures
contain laminin 1 and 1 chains (laminin-1) and 1(IV) and 2(IV) chains of collagen type IV. (B) Beginning with the glomerular capillary loop
stage of development, laminin 5 and 2 chains (laminin-11) and 3(IV), 4(IV), and 5(IV) collagen chains are normally observed. Alport
GBMs, however, lack 3(IV), 4(IV), and 5(IV) collagen. (C ) GBMs of maturing stage glomeruli normally contain laminin 5 and 2 (lami-
nin-11) and 3(IV), 4(IV), and 5(IV) collagen. Laminin-1 and collagen 1(IV) and 2(IV) chains have disappeared. In Alport kidneys, lami-
nin-1 is reexpressed and found together with laminin-11, as well as 1(IV) and 2(IV) collagen. (Laminin 2 chain is also present in Alport
glomerular basement membranes (GBMs) [12], but the timing of its appearance during glomerular development is not yet known). (Redrawn
from reference [17]).
Although dynamic reciprocities between the endothe- which do not assemble functional laminin-11, still un-
dergo the normal collagen IV isoform switching pro-lium-GBM-podocytes surely occur, exactly how laminin
and collagen IV isoform substitutions are regulated at gram, despite compensatory synthesis of laminin-1 [11],
suggesting that collagen IV and laminin genes are con-either the gene or protein level are very poorly un-
derstood. Patients with nail patella syndrome have mu- trolled independently. In contrast, the absence of colla-
gen 3(IV) chain in the Alport mouse clearly affectstations encoding a LIM sequence motifs, first identified
in homeodomain proteins Lin-11, Isl-1, and Mec-3, Lmx1b, laminin isoform expression, but mechanisms underlying
this laminin dysregulation are utterly unknown.and some of these patients have GBM abnormalities as
well [19]. Recently, Lmx1b has been shown to regulate ex- How does GBM laminin dysregulation, together with
the diffuse absence of collagen 3, 4, and 5(IV), leadpression of COL4A3 and COL4A4, as well as the NPHS2
(podocin) and CD2AP genes [20–22]. Although these find- to the glomerular structural and functional abnormalities
of Alport disease? This issue raises several difficult ques-ings show that expression of certain basement membrane
and slit diaphragm complex proteins may be coordinated tions. First, we considered the possibility that the lami-
nin-1 chains seen in Alport GBMs were derived by errantin podocytes, there is little understanding of how this may
affect regulation of the other collagen type IV chains or translocation out of the mesangial matrix, a site where
laminin-1 normally resides in the mature mouse glomer-any of the laminin isoforms. Indeed, laminin 2 null mice,
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ulus. However, we showed by immunoelectron micros- protein genes are activated and silenced under normal
copy that laminin-1 chains were found within the intra- and abnormal conditions. Perhaps continued studies on
cellular biosynthetic pathways in both endothelial cells laminin dysregulation in the Alport mouse will shed
and podocytes, indicating that some if not all of Alport more light on this problem.
GBM laminin-1 was derived from glomerular capillary
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